
手機掃碼訪問本站

微信咨詢
猜你喜歡
- 2,5-Pyridinedicarboxylic Acid-13C8,d3
- 4-羥基-2-氯聯(lián)苯
- 2-(2-Fluoro-4′-Methoxy-[1,1′-biphenyl]-4-yl)propanal
- 乙酸鈥水合物
- 668270-12-0 / 新型DPP-4抑制劑利格列汀的獨特藥理學性質(zhì)
- (5Z,9Α,11RS,13E,15S)-9,11,15-三羥基血栓氧-5,13-二烯-1-烏蘇酸
- 米卡芬凈鈉雜質(zhì)
- 2-氯喹啉-6-磺酰氯
- 2-METHOXY-5-[1,3]OXAZOLO[4,5-B]PYRIDIN-2-YLANILINE
- 1,2-二氫-2-氧代腺苷水合物
- 1-BROMO-4,4,5,5,6,6,6-HEPTAFLUORO-3,3-BIS(TRIFLUOROMETHYL)HEXANE
- (2RS,3RS)-1-AMINO-3-(2-ETHOXYPHENOXY)-2-HYDROXY-3-PHENYLPROPANE, METHANESULFONATE SALT
- 3,3′-雙噻吩
- 4-(甲基磺酰氧基)苯硼酸
- 5329-14-6 / 一種氨基磺酸生產(chǎn)工藝
- (N-(對羥基乙基)-N-(2-溴-5-羥基-4-甲氧基))甲酰胺
- 鄰甲基苯甲酸
- DI-T-BUTYLTON OXIDE
- 氟化銪
- 6-Chloro-5-[(4,5-dihydro-1H-iMidazol-2-yl)aMino]-2-Methyl-4(1H)-pyriMidinone
- 144-55-8 / 碳酸氫鈉的制劑方法
- 4-Mercaptocinnamic Acid Methyl Ester
- 間硝基三氟甲氧基苯
- 6-Chloro Pantoprazole
- 4-(2-吡啶基乙酰基)苯甲酸